Originally published In Press as doi:10.1074/jbc.M209071200 on October 14, 2002
J. Biol. Chem., Vol. 277, Issue 49, 47946-47953, December 6, 2002
Mitochondrial DNA Instability Mutants of the Bifunctional Protein
Ilv5p Have Altered Organization in Mitochondria and Are Targeted for
Degradation by Hsp78 and the Pim1p Protease*
Joseph M.
Bateman,
Michelina
Iacovino,
Philip S.
Perlman, and
Ronald A.
Butow
From the Department of Molecular Biology, University of Texas
Southwestern Medical Center, Dallas, Texas 75390-9148
Received for publication, September 5, 2002, and in revised form, October 4, 2002
 |
ABSTRACT |
Ilv5p is a bifunctional mitochondrial protein in
Saccharomyces cerevisiae required for branched-chain amino
acid biosynthesis and for the stability of wild-type (
+)
mitochondrial DNA (mtDNA). Mutant forms of Ilv5p defective in mtDNA
stability (a+D
) are present as 5-10 punctate
structures in mitochondria, whereas mutants lacking enzymatic function
(a
D+) show a reticular distribution, as does
wild-type Ilv5p. a+D
ilv5
mutations are recessive, and the mutant protein is redistributed to a
reticular form when co-expressed with wild-type Ilv5p. Ilv5p proteins that are punctate in vivo are also less
soluble in detergent extracts of isolated mitochondria, suggesting that
the punctate foci in a+D
Ilv5p mutants are
aggregates of the protein. a+D
Ilv5p proteins
are selectively degraded in cells lacking a functional mitochondrial
genome, but only in cells grown under derepressing conditions. The
targeted degradation of a+D
Ilv5p, which
occurs even when co-expressed with wild-type Ilv5p, is mediated by the
glucose-repressible chaperone, Hsp78, and by the
ATP-dependent Pim1p protease, whose activity may be
modulated by
+ mtDNA.
 |
INTRODUCTION |
The stability and inheritance of mitochondrial DNA
(mtDNA)1 in
Saccharomyces cerevisiae depends on a surprisingly large
number of proteins, some of which would not have been anticipated to be
involved in mtDNA transactions (1). One example is Ilv5p, a
mitochondrial NADPH-requiring acetohydroxyacid reductoisomerase that
catalyzes parallel steps in the biosynthesis of branched-chain amino
acids (2, 3). Cells that lack Ilv5p are blocked in branched-chain amino
acid biosynthesis and therefore require isoleucine, leucine, and valine
for growth. An unanticipated function for Ilv5p in mtDNA transactions
was revealed in studies of suppression of a mtDNA instability phenotype
in cells with a deletion of the ABF2 gene (4). Abf2p
is an abundant high mobility group-box protein that binds
non-specifically to mtDNA (5) and is likely to be involved in mtDNA
packaging (6-8). mtDNA is rapidly lost from abf2
cells grown under conditions that are not selective for respiration,
i.e. on fermentable carbon sources (8). Overexpression of
Ilv5p by as little as 2- to 3-fold is sufficient to suppress the mtDNA
instability phenotype of abf2
cells (4). Moreover, wild-type (
+) mtDNA is unstable in ilv5
cells, leading to the production of 
petites (which
contain amplified fragments of the
+ genome). Finally,
Ilv5p has also been shown to be involved in the redistribution of mtDNA
nucleoids, which occurs in response to amino acid starvation (9). These
effects do not depend on the operation of the branched-chain amino acid
biosynthetic pathway, because deletion of another essential gene in
that pathway, ILV2, has no effect on mtDNA stability (4).
These studies led to the conclusion that Ilv5p is a bifunctional
protein required for the synthesis of branched-chain amino acids and
for mtDNA transactions.
Further evidence for the bifunctional nature of Ilv5p has come from a
detailed mutational analysis of the protein (10). Recessive point
mutants of Ilv5p were identified that resulted in either the loss in
Ilv5p of branched-chain amino acid biosynthetic function
(a
D+) or its mtDNA stability function
(a+ D
). Like ilv5
cells,
+ mtDNA was unstable in a+ D
mutants and gave rise to 
petites. In some of the
a+ D
mutants, 
petites were
produced at rates comparable to that of ilv5
cells, whereas other mutants of this class displayed either a weaker or a
stronger (hypermorphic) mtDNA instability phenotype. The affected
residues of the two classes of point mutants of Ilv5p cluster to
distinct and different regions of the 3-dimensional structure of the
spinach ortholog of Ilv5p. That protein has 31% sequence identity with
yeast Ilv5p and is the only structure currently available for an
acetohydroxyacid reductoisomerase (11). Mutations of the
a
D+ class map to a region buried within the
core of the protein at or close to residues known to bind the substrate
and cofactors, NADPH and Mg2+. By contrast, the majority of
mutations of the a+ D
class map within or
adjacent to two
-helices, also present in Ilv5p of yeast, that are
on the surface of the spinach protein. These data suggested that the
a+ D
mutations could affect intermolecular
interactions of the yeast Ilv5p. The mtDNA redistribution function of
Ilv5p (9) was also found to be defective in
a+D
mutants (10), suggesting that the
stability and organizational state of mtDNA nucleoids are functionally
linked. Finally, none of these mtDNA transaction defects is observed in
the a
D+ mutants, further confirming that
branched-chain amino acid biosynthesis per se is not
connected to these mtDNA activities.
We show here that the a+D
mutant proteins are
present as a small number of aggregated, punctate structures within
mitochondria and that the extent of aggregation is related to the
severity of the mtDNA instability phenotype. In contrast, wild-type
Ilv5p and the a
D+ mutants have a distinctly
reticular distribution within mitochondria. Surprisingly, we find that
the a+D
mutant proteins are unstable in
petite cells, but not in
+ cells, and that the
instability is glucose-repressible. This instability is independent of
the organizational state of the a+D
mutant
protein and can be attributed to the Pim1p protease, whose activity we
have found to be regulated by the glucose-repressible chaperone Hsp78.
 |
EXPERIMENTAL PROCEDURES |
Strains and Growth Conditions--
All strains described were
derivatives of either 14CWW (MATa ade2-1
ura3-52 trp1 leu2-3,112
+
(10); 14CWW
ilv5 (MATa ade2-1
ura3-52 trp1 leu2-3,112 ilv5::URA3
+ (10); or 14CWW
ilv5u
(MATa ade2-1 ura3-52 trp1
leu2-3,112 ilv5:: ura3
+).
Strains I267F and W327R (containing at the ILV5 locus
integrated copies of weak and strong a+D
mutant alleles, respectively), or D255E (containing an integrated a
D+ allele at the ILV5 locus),
were created by transplacing each mutant allele into strain
14CWW
ilv5. ILV5his and W327Rhis strains were
created by transplacing the respective His6-tagged alleles into strain 14CWW
ilv5. The 
petite
genome HS40 was introduced into strains by cytoduction as described
(9).
° strains were produced by passage of cells through liquid
YPD medium containing 25 µg/ml ethidium bromide.
Diploid strains 303V5/14V5G, 303W327R/14V5G, and 303W327R/14W327RG were
created by transplacing the a+D
mutant allele
W327R into a W303 (MAT
leu2-3,112
his3-11,15 trp1-1 can1-100
ade2-1 ura3-1) strain carrying the
ilv5::ura3 null allele (4) at the ILV5
locus, then mating this strain (303W327R) or wild-type W303 with 14CWW
strains carrying wild-type ILV5-GFP or
a+D
mutant W327R-GFP alleles. Diploid strains
14V5/14V5G and 14W327R/14V5G were created by transplacing the wild-type
ILV5-GFP allele into strain 14CWW
ilv5 at the
ILV5 locus, then mating-type switching this strain using
pGAL-HO (12), to create strain
ILV5-GFP, which was mated
with strain 14CWW or W327R, respectively.
Deletion of HSP78 and PIM1 was performed by PCR
amplification of the respective KanMX4 deletion module from the
commercially available strains (Research Genetics, Invitrogen, CA).
These PCR products were then used to replace the wild-type genes in
° isolates of 14CWW or W327R. All transplaced mutant alleles and
deleted genes were confirmed by PCR, Southern analysis, or DNA
sequencing. Cells were grown at 30 °C in YP medium (1% yeast
extract and 2% Bacto-Peptone) containing either 2% dextrose (YPD),
3% glycerol (YPGly), or 2% raffinose (YPRaff), or YNB medium (0.67%
yeast nitrogen base without amino acids) containing 1% casamino acids and either 2% dextrose (YNBD+cas) or 3% glycerol (YNBGly+cas), or 2%
raffinose (YNBRaff+cas). Additional amino acids were supplemented as required.
Plasmid Construction--
Construction of plasmids containing
a+D
mutants I267F and W327R and
a
D+ mutant D255E was described previously
(10). The GFP-tagged fusion of wild-type ILV5 was
constructed as follows. Using the primers
5'-ACCTCTAGTGGATCCGTAGATGTAATC-3' and
5'-TTATTTTCCTCGAGATTGGTTTTCTGGTC-3', a 2379-bp fragment
containing the ILV5 promoter and coding sequence was
amplified from pRS-ILV5 (4) and digested with
BamHI and XhoI. The coding sequence of bGFP was
then excised from pGEM7zf(+)bGFP, containing bGFP (13), cloned into the
XhoI/KpnI sites in pGEM7zf(+) (Promega), using
XhoI and HindIII. The ILV5 fragment
was fused to bGFP by excising the BamHI/HindIII
fragment from pBS-ILVc+3' (10) and ligating the
BamHI/XhoI ILV5 fragment, along with
the XhoI/HindIII bGFP fragment, into the
remaining vector to produce pBS-ILV5GFP. The
BamHI/BlpI fragment from this vector was then used to replace the same fragment in pRS-ILV5 to produce
pRS-ILV5GFP. The mutant ILV5 proteins were
GFP-tagged in a similar fashion.
Wild-type ILV5 and the W327R ilv5 mutant were
tagged with His6 by mutagenizing both pRS-ILV5
(4) and pRSW327R (10), using the Muta-Gene Phagemid In Vitro
Mutagenesis kit (version 2, Bio-Rad), so as to incorporate the
His6 sequence before the stop codon.
p416TEFHSP78 was created by amplifying HSP78,
lacking its own promoter, from genomic DNA using primers
5'-GAAAATCTTACTAGTTTAAATATGTTAAG-3' and
5'-CTTGTCGACTTACTTTTCAG-3', then digesting with
SpeI and SalI and ligating this fragment into
p416TEF (14) at the same sites.
Mitochondrial Purification, Lysis, and Affinity
Chromatography--
Mitochondria were purified as described previously
(15), except that the sucrose gradient floatation step was omitted.
Mitochondria were divided into 0.5 mg or 1 mg aliquots, resuspended in
100 µl of lysis buffer (50 mM NaCl, 50 mM
imidizole (Sigma)/HCl, 5 mM
-amino-n-caproic
acid (Sigma), 0.5 mM phenylmethylsulfonyl fluoride,
1 µg/ml aprotinin (U. S. Biological), 1 µg/ml leupeptin (Sigma)), incubated on ice for 5 min, and lysed by adding 2 g of
n-dodecylmaltoside (Roche) per g of mitochondria and
incubating on ice for 10 min. Insoluble material was then isolated by
centrifugation of the lysed mitochondria for 20 min at 20,817 × g. The pellet was then resuspended in an equal volume of 1×
SDS-PAGE loading buffer (0.125 M Tris/HCl, 1% SDS, 4%
glycerol, 100 mM dithiothreitol, 0.002% bromphenol blue,
pH 6.8). For Ni2+ chromatographic purification of
His6-tagged Ilv5p, purified mitochondria were resuspended
to between 1 and 2 mg/ml in column buffer (50 mM
NaH2PO4, 50 mM KCl, 10 mM imidizole, 0.5 mM phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin, 1 µg/ml leupeptin, 1× CompleteTM
EDTA-free protease inhibitor mixture (Roche)). Resuspended mitochondria were then broken by sonication on ice for four periods of 15 s at
7% output, using a Branson Sonifier 450 (Danbury, CT). Broken mitochondria were centrifuged for 30 min at 20,400 × g. The pellet was then resupended in an equal volume of
column buffer, and the supernatant was added to 1 ml of
nickel-nitrilotriacetic acid agarose (Qiagen) which had been washed in
column buffer and gently mixed in a Poly-Prep chromatography column
(Bio-Rad) for 1 h at 4 °C. The column was then washed with 15 ml of wash buffer (the same as column buffer with the imidizole
concentration increased to 20 mM), and the bound protein
was eluted with three sequential additions of 0.5 ml of elution buffer
(the same as column buffer with the imidizole concentration increased
to 250 mM and the addition of 20% glycerol).
Western Blot Analysis--
Trichloroacetic acid precipitates of
total yeast cell proteins were prepared from OD600 0.6-1.0
cultures as described previously (16). For SDS-PAGE, equal volumes of
extract were solubilized in 1× SDS-PAGE loading buffer (see above);
samples were loaded onto 10% SDS-PAGE gels and separated using the
Ready Gel system (Bio-Rad). Proteins were transferred to nitrocellulose
membranes (Schleicher & Schuell) using a Hoefer SemiPhor semidry
transfer apparatus (Amersham Biosciences). Immunodetection of
proteins was carried out using primary rabbit anti-Ilv5p (15) and mouse anti-Porin (Molecular Probes). Anti-rabbit or anti-mouse immunoglobulin G-coupled horseradish peroxidase (Bio-Rad) were used as secondary antibodies and were visualized using the ECL system (Amersham Biosciences).
Fluorescence Microscopy--
Log-phase cells were observed live
using a Leica microscope (model DMRXE) equipped with an HBO 100 W/2
mercury arc lamp, and a 100× Plan-Apochromat objective lens.
Differential interference contrast and green fluorescent protein
were visualized using filter sets described previously (13).
Mitotracker was visualized using 515-560 nm excitation and >590 nm
long pass emission filters. Images were captured with a color-chilled
three charge-coupled device camera system (model C5810; Hamamatsu
Photonics) and processed using Adobe Photoshop (Adobe Systems, Inc.).
Cells were stained with Mitotracker Red CM-H2XRos
(Molecular Probes), by adding Mitotracker to log-phase growing cells to
a final concentration of 0.5 µM and incubating for 20 min
at 30 °C, and pelleting the cells and washing three times in
distilled water, before microscopy.
Petite Assay--
To measure petite formation in the various
strains, mid-log-phase cultures of strains grown in YNBGly+cas medium
were transferred to YNBD+cas medium and grown for at least thirty
generations. At various time points, cells were plated onto YNBD+cas
plates and grown for 3 days at 30 °C.
+ and petite
colonies were distinguished by 2,3,5-triphenyltetrazolium chloride
(TTC) overlay (17), using 0.2% TTC (Sigma) with 0.8% agarose. Between
fifty and three hundred colonies were counted for each time point.
 |
RESULTS |
a+D
ilv5 Mutants Have Variable mtDNA
Instability Phenotypes and Form Punctate Structures within
Mitochondria--
To obtain additional insight into the bifunctional
nature of Ilv5p, we analyzed three Ilv5p mutants: two
a+D
mutants, I267F and W327R, defective in
+ mtDNA stability, and one a
D+
mutant, D255E, which has no effect on mtDNA stability but is defective
in branched-chain amino acid biosynthesis. Centromeric vectors
containing these mutant alleles, wild-type ILV5, or no insert were transformed into ilv5
cells. These
transformants were pre-grown on glycerol medium (YNBGly+cas) to
maintain
+ mtDNA and then transferred to glucose medium
(YNBD+cas) and grown for at least thirty generations. At various time
points, samples of each culture were plated onto YNBD+cas medium to
determine the percentage of
+ cells in the population.
In accordance with our previous results (10),
+ mtDNA
was unstable in ilv5
cells containing the empty vector, whereas it was completely stable in cells containing wild-type ILV5, or the a
D+ mutant D255E
allele (Fig. 1). Although
+ mtDNA was unstable in both of the
a+D
mutants, the degree of mtDNA instability
was significantly different between them and ilv5
cells
containing the control plasmid. Specifically, a+D
mutant I267F has a weaker
mtDNA-instability phenotype than ilv5
cells, whereas
a+D
mutant W327R has a much stronger
mtDNA-instability phenotype than ilv5
cells (Fig. 1). We
refer to these a+D
mutant alleles as weak and
strong, respectively.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Ilv5 mutants have different
mtDNA-instability phenotypes.
14CWW ilv5u cells transformed with either
wild-type ILV5 on a centromeric plasmid, empty vector
(ilv5 ), or the indicated ilv5
a D+ or a+D mutant
allele were pre-grown in YNBGly+cas then shifted to YNBD+cas medium.
Aliquots were removed at the time points indicated and scored by TTC
overlay (17) for the fraction of petites in the population.
|
|
To determine how these mutant forms of Ilv5p are distributed in
mitochondria, we constructed C-terminal GFP fusion genes of wild-type
Ilv5p and each of the mutant proteins and expressed these under control
of the ILV5 promoter from centromeric plasmids transformed
into
+ cells of strain
14CWW
ilv5u
. The wild-type yeast GFP fusion
protein complemented all of the phenotypes of ilv5
cells,
whereas the mutant derivatives reproduced the phenotypes of their
respective untagged forms (data not shown). Although all of the
Ilv5p-GFP fusions localized to mitochondria when visualized by
fluorescence microscopy, there was a dramatic difference in the
distribution of these proteins, which correlated with their effects on
mtDNA stability: both the wild-type and the
a
D+ mutant fusion protein, D255E, had a
largely reticular morphology typical of a mitochondrial matrix protein
(Fig. 2A). By contrast, both
the strong (W327R) and the weak (I267F) a+D
GFP-tagged alleles were mainly localized to just a few foci in mitochondria (on average between 5 and 10 when all sections throughout the cells were examined). Closer inspection of the distribution of
these GFP-tagged proteins in mitochondria also indicated that some of
the I267F a+D
Ilv5p-GFP was also reticular.
The punctate distribution of the a+D
Ilv5p-GFP mutant proteins is not due to an alteration in mitochondrial morphology, because strains expressing these proteins exhibit normal
mitochondrial structures as revealed by staining with MitoTracker (Fig.
2B). This reticular structure persists in wild-type and a+D
mutant 
and
o petite cells (data not shown).

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 2.
a+D
mutant Ilv5p-GFP fusion proteins localize as punctate structures
within mitochondria. A, Ilv5 cells were
transformed with plasmids containing GFP fusions of wild-type
ILV5, a+D mutants W327R and I267F,
and a D+ mutant D255E. Representative cells
are shown, using differential interference contrast and fluorescence
microscopy to visualize GFP. B, Ilv5p distribution was
visualized in strain 14CWW ilv5u expressing
either wild-type Ilv5p-GFP, or a+D W327R
Ilv5p-GFP, and mitochondrial morphology was visualized by staining with
MitoTracker (MT). C, a plasmid containing
a+D ilv5 mutant W327R Ilv5p-GFP
was transformed into either the ILV5 wild-type strain 14CWW
or into strain 14CWW ilv5u . D,
 (HS40) or o cells of strain
14CWW ilv5u were transformed with a plasmid
containing a+D ilv5 mutant W327R
Ilv5p-GFP. All strains were grown to mid-log phase in YNBGly+cas
medium. Bar = 3 µm.
|
|
The above findings raise the possibility that the mtDNA instability
phenotype of the ilv5 a+D
mutants
is related to their propensity to form punctate structures in
mitochondria. Previous genetic studies established that all of the
ilv5 a+D
mutants are recessive
(10). This includes not only the mtDNA instability phenotype, but also
the temperature-sensitive growth phenotype of ilv5
a+D
cells grown in medium containing a
non-fermentable carbon source. Thus it was of interest to determine
whether the punctate morphology of the a+D
mutant Ilv5p-GFP persists when co-expressed with wild-type Ilv5p. To
address this, we introduced a centromeric plasmid containing the
a+D
mutant, W327R Ilv5p-GFP, into
ILV5 14CWW wild-type cells expressing untagged Ilv5p and
compared the mutant Ilv5p-GFP morphology to that in strain
14CWW
ilv5u
transformed with the same
plasmid. The results of this experiment (Fig. 2C) show that
there was a dramatic redistribution of W327R Ilv5p-GFP from tight,
punctate structures when expressed alone to a largely reticular
distribution when co-expressed with untagged, wild-type Ilv5p. This
redistribution of a+D
mutant Ilv5p-GFP was
also seen when a strain containing an integrated copy of W327R
Ilv5p-GFP was transformed with pRS-ILV5 encoding wild-type
Ilv5p (data not shown). Taken together, these data suggest that the
unusual punctate distribution of mutant a+D
Ilv5p is related to the defects in mtDNA transactions.
Although wild-type Ilv5p shows a largely reticular distribution within
mitochondria, Ilv5p has been recovered as a component of the mtDNA
nucleoid (15), suggesting some functional partitioning of the protein.
Because there are fewer a+D
Ilv5p-GFP
punctate structures than
+ mtDNA nucleoids, it has been
difficult to assess with certainty whether these punctate structures
co-localize with
+ mtDNA. However, we can ask whether
the punctate morphology of a+D
Ilv5p-GFP
depends on the presence of mtDNA. To this end, we transformed the
centromeric plasmid containing W327R Ilv5p-GFP into a
° derivative of strain 14CWW
ilv5u
and examined the
distribution of the protein in cells. The same plasmid was also
transformed into the strain 14WW
ilv5u
HS40
containing the 
mtDNA HS40 (which consists of a 760-bp
tandemly repeated fragment of the
+ genome). The same
punctate foci of the a+D
mutant Ilv5p-GFP
were seen in these
° and 
cells as in the
+ parent strain (Fig. 2D), indicating that
the punctate distribution of a+D
protein
occurs independently of mtDNA.
a+D
Ilv5p Solubility Is Decreased in
Mitochondria--
To gain additional insight to the intriguing
differences between the a+D
mutant proteins
and the a
D+ mutant and wild-type proteins, we
determined the relative efficiency of solubilization of these proteins
by extracting mitochondria isolated from cells expressing each of these
proteins with the non-ionic detergent n-dodecylmaltoside
(see "Experimental Procedures"). The mitochondrial extracts were
separated into supernatant and pellet fractions, which were then
analyzed by Western blotting to determine the distribution of Ilv5p and
the outer membrane marker protein, porin (Fig.
3A). Whereas porin, wild-type
Ilv5p, and a
D+ Ilv5p were nearly completely
solubilized by n-dodecylmaltoside, only about 40% of the
strong (W327R) and 70% of the weak (I267F) a+D
Ilv5p mutants were solubilized by this
treatment. These data correlate with the respective morphological
distribution of the wild-type and mutant Ilv5p-GFP fusion proteins
(Fig. 2A) and suggest that the punctate structures formed by
Ilv5p in the a+D
mutants are aggregated
species with reduced detergent solubility compared with wild-type and
a
D+ mutant Ilv5p.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 3.
a+D
ilv5 mutant proteins have decreased detergent
solubility, which can be reversed by co-expression of wild-type
Ilv5p. A, mitochondria were isolated from cells
expressing wild-type Ilv5p (ILV5),
a D+ mutant (D255E), strong (W327R), or weak
(I267F) a+D mutant derivatives, solubilized
by treatment with n-dodecylmaltoside, separated into
supernatant (S) and pellet (P) fractions, and the
distribution of Ilv5p was analyzed by Western blotting. All cells were
grown in YPG medium. To confirm that mitochondria had been efficiently
solubilized, the distribution of the outer membrane protein porin was
also analyzed. B, mitochondria isolated from diploid strains
(303V5/14V5G, 303W327R/14V5G, and 303W327R/14W327RG) expressing either
wild-type Ilv5p and wild-type Ilv5p-GFP (ILV5/ILV5-GFP),
a+D W327R mutant Ilv5p, and wild-type
Ilv5p-GFP
(a+D /ILV5-GFP),
or a+D W327R mutant Ilv5p and
a+D W327R mutant Ilv5p-GFP
(a+D /a+D -GFP)
grown in YPG medium were solubilized with
n-dodecylmaltoside, separated into supernatant
(S) and pellet (P) fractions, and analyzed as in
A.
|
|
Because a+D
mutant Ilv5p is redistributed in
mitochondria from a punctate to a largely reticular morphology when
co-expressed with wild-type Ilv5p, we could ask whether the reduced
detergent solubility of a+D
mutant Ilv5p was
a consequence of its organizational state within mitochondria, or some
intrinsic property of the mutant protein, independent of how it is
organized. When mitochondria from glycerol-grown diploid cells
co-expressing wild-type Ilv5p-GFP and untagged
a+D
W327R mutant protein were extracted with
n-dodecylmaltoside, much more of the mutant protein was
solubilized by the detergent than when both untagged and GFP-tagged
mutant proteins were co-expressed (Fig. 3B). As expected,
both the GFP-tagged and untagged wild-type Ilv5p were nearly completely
solublized by n-dodecylmaltoside. These data suggest that
the solubility of the mutant protein in n-dodecylmaltoside
is related to its organizational state in mitochondria.
Interaction between Wild-type and a+D
Mutant Ilv5p--
One explanation for the redistribution of
a+D
mutant Ilv5p when co-expressed with
wild-type Ilv5p is that the wild-type protein interacts with the
a+D
mutant protein, preventing its
aggregation. To test for an interaction between these proteins, we
constructed C-terminal His6-tagged derivatives of wild-type
ILV5 and W327R a+D
mutant
ilv5 and integrated these at the ILV5 locus to
produce strains ILV5his and W327Rhis, respectively. Strain
ILV5his was then transformed with a plasmid expressing
wild-type Ilv5p-GFP, whereas strain W327Rhis was transformed with
plasmids expressing either wild-type Ilv5p-GFP or
a+D
mutant W327R Ilv5p-GFP. As a control, the
wild-type strain 14CWW was transformed with the plasmid expressing
wild-type Ilv5p-GFP. Mitochondria from these strains were isolated and
broken by sonication, and the soluble extracts were chromatographed on
nickel-nitrilotriacetic acid agarose (see "Experimental
Procedures"). Bound and unbound material was then analyzed by Western
blotting with anti-Ilv5p antiserum, which detects both the
His6- and GFP-tagged forms. The results of these
experiments (Fig. 4,
A-C) show that, in all of the combinations of
wild-type and mutant Ilv5p examined, affinity purification of either
wild-type or mutant His6 derivatives resulted in co-elution
of the corresponding wild-type or mutant GFP-tagged form, whereas no
material was found in the bound fraction in the control lacking a
His6-tagged derivative (Fig. 4D). These data show that different forms of Ilv5p can interact and suggest that the
association between a+D
mutant and wild-type
Ilv5p prevents aggregation of the mutant Ilv5p.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
Interaction between wild-type Ilv5p and
a+D mutant Ilv5p.
Plasmids containing wild-type ILV5-GFP or
a+D mutant W327R-GFP were transformed into
strain ILV5his and W327Rhis, expressing
His6-tagged isoforms of the wild-type or
a+D mutant W327R Ilv5p, respectively. As a
control, the plasmid containing ILV5-GFP was also
transformed into strain 14CWW expressing untagged, wild-type Ilv5p as a
control. Soluble mitochondrial extract (S) from these
strains, grown in YNBGly+cas medium, was then chromatographed on
Ni2+ resin. The bound (B) material was eluted by
addition of 250 mM imidazole, and the bound and unbound
(UB) fractions were analyzed for the presence of Ilv5p by
Western blotting. A, strain ILV5his co-expressing
wild-type Ilv5p-GFP. B, strain W327Rhis co-expressing
wild-type Ilv5p-GFP. C, strain W327Rhis co-expressing
a+D mutant W327R Ilv5p-GFP. D,
strain 14CWW co-expressing wild-type Ilv5p-GFP.
|
|
a+D
Mutant Ilv5p Is Unstable in Petite
Cells, and the Instability Is Glucose-repressible--
Although
microscopy experiments indicated that the punctate morphology of the
strong a+D
mutant protein is independent of
mtDNA (Fig. 2D), we noticed that there was a significant
decrease in the abundance of a+D
mutant W327R
Ilv5p in
° petite cells grown in raffinose medium. To investigate
this further, we compared the abundance of Ilv5p in wild-type, the
a
D+ mutant, and both the strong and weak
a+D
Ilv5p mutants in
+,

, and
° petite cells grown in media containing
different carbon sources. Because
+ mtDNA is unstable in
a+D
cells grown on fermentable carbon
sources, we carried out our initial analysis of the stability of the
various forms of Ilv5p in
+ cells grown in glycerol
medium. Under these conditions, wild-type and mutant forms of Ilv5p
were present at comparable abundance (Fig.
5A). However, in either a

or a
° petite strain grown on raffinose, a
non-repressing, fermentable carbon source, both of the
a+D
mutant proteins were unstable, whereas
neither wild-type Ilv5p nor the a
D+ mutant
Ilv5p were affected (Fig. 5, B and D). By
contrast, when these petite strains were grown in glucose medium, the
a+D
mutant proteins were as stable as the
wild-type or a
D+ mutant protein (Fig. 5,
C and E). These data suggest that one or more
factors accounting for the instability of the
a+D
mutant proteins in petites is
glucose-repressible. The extent of the instability of Ilv5p in the
strong and weak a+D
mutants (Fig. 5,
B and D) also correlated with the severity of the
mtDNA instability phenotype associated with these mutations (Fig. 1).
Fig. 5 (B and D) show that the level of Ilv5p in
the strong mutant, W327R, was severalfold lower than that of the weak mutant, I267F. Northern blot analysis revealed that there was no
difference in the mRNA abundance of wild-type and mutant
ilv5 transcripts in cells grown in the different media noted
above (data not shown), indicating that the cause of the instability of
the a+D
mutant proteins is
post-transcriptional.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 5.
a+D
mutant Ilv5p is selectively unstable in petite cells grown under
derepressing conditions. A, whole-cell extracts of
+ strains expressing wild-type (WT) Ilv5p,
strong W327R (S), and weak I267F (W)
a+D Ilv5p mutants, or the
a D+ mutant, D255E, were grown to mid-log
phase in YPG medium and analyzed by Western blotting for the abundance
of the different forms of Ilv5p, using porin as a loading control.
 (HS40) derivatives of the same strains used in
A were grown in either raffinose medium (B) or
glucose medium (C), and the level of Ilv5p determined was
determined as in A. o derivatives of the same
strains used in A were grown in either raffinose medium
(D) or glucose medium (E) and analyzed as in
A.
|
|
We wanted to compare the stability of the wild-type and mutant forms of
Ilv5p in
+ and petite cells grown on identical carbon
sources and to determine whether the organizational state of
a+D
mutant Ilv5p proteins is an underlying
factor in the instability of these mutant proteins. To do this we used
a
+ diploid strain (W327R/ILV5-GFP), in which
the W327R a+D
mutant allele was complemented
by a wild-type copy of ILV5-GFP. Given that
a+D
ilv5 mutations are recessive,
+ mtDNA would be stable in those cells grown in
raffinose or glucose medium. As a control, we used the diploid strain
ILV5/ILV5-GFP containing untagged and GFP-tagged wild-type
ILV5 alleles. In W327R/ILV5-GFP
° cells, the
mutant Ilv5p was unstable when those cells were grown on raffinose
medium, exactly as we had observed in cells expressing only the mutant
Ilv5p (Fig. 6A). As expected, the mutant Ilv5p was stable in W327R/ILV5-GFP
° cells
grown on dextrose (data not shown). By contrast, in
W327R/ILV5-GFP
+ cells grown on raffinose
medium, the mutant Ilv5p was stable (Fig. 6B). These
findings exclude the possibility that the instability of the
a+D
mutant Ilv5p in petites is simply a
consequence of growth on raffinose medium. Importantly, these data also
suggest that the instability of the a+D
mutant Ilv5p is not related to the in vivo distribution of
the protein, but rather, that the instability is an intrinsic property of the a+D
proteins. Finally, we have also
observed that a+D
mutant Ilv5p is stable in
+ W327R/ILV5-GFP cells grown on raffinose
medium in the presence of the respiratory chain inhibitor antimycin A
or the ATP synthase inhibitor oligomycin (data not shown). We conclude
that the instability of the a+D
mutant Ilv5p
in petites is a consequence of the absence of a functional
mitochondrial genome rather than simply the loss of oxidative
phosphorylation capacity.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
The instability of
a+D mutant Ilv5p does
not depend on its aberrant organization within mitochondria.
A, o derivatives of diploid strains
14V5/14V5G and 14W327R/14V5G expressing either wild-type Ilv5p and
wild-type Ilv5p-GFP (ILV5/ILV5-GFP) or
a+D W327R mutant Ilv5p and wild-type
Ilv5p-GFP
(a+D /ILV5-GFP)
were grown to mid-log phase in raffinose medium. The relative amount of
Ilv5p in cell extracts from each strain was then analyzed by Western
blotting, using porin as a loading control. B,
+ parent strains 14V5/14V5G
(ILV5/ILV5-GFP) and 14W327R/14V5G
(a+D /ILV5-GFP)
were grown and analyzed as in A.
|
|
a+D
Mutant Ilv5p Is Degraded by the Pim1p
Protease, and the Activity Is Regulated by the Glucose-repressible
Chaperone Hsp78--
The results presented thus far indicate that the
a+D
mutant Ilv5p is unstable in derepressed
cells lacking a functional mitochondrial genome. Examination of
microarray data from cells undergoing the diauxic shift (18) did not
reveal any known mitochondrial protease in which expression was
significantly repressed by glucose. However, the expression of Hsp78, a
mitochondrial chaperone that has significant sequence similarity to
Escherichia coli ClpB, as well as to ClpA and
ClpX
polypeptides that form a complex with the proteolytic subunit
ClpP to yield an oligomeric ATP-dependent protease in E. coli (19, 20)
was increased by 6-fold on depletion of
glucose from the medium. This observation concurs with an earlier
report showing that expression of HSP78 was repressed 3- to
5-fold in cells grown on glucose medium (21). Although there is no
known protein with significant sequence similarity to E. coli ClpP in yeast, we nevertheless investigated the possibility
that Hsp78 might function in concert with other proteins in the
turnover of a+D
mutant Ilv5p.
We confirmed that in the strains used in this study, the level of the
HSP78 transcript was glucose-repressible (data not shown). To determine whether Hsp78 was involved in the instability of a+D
mutant Ilv5p, we first deleted
HSP78 in wild-type and a+D
mutant
strains and determined the level of Ilv5p in
o isolates
of these strains grown in raffinose medium, conditions in which
a+D
mutant Ilv5p is otherwise unstable. The
level of wild-type Ilv5p was unaffected in hsp78
o cells, whereas a+D
mutant
Ilv5p was still unstable in that genetic background (Fig. 7A). However, we observed a
slight but reproducible increase in the level of
a+D
mutant Ilv5p in hsp78
cells
compared with the wild-type HSP78 control cells. Although
these data rule out the possibility that Hsp78 is the sole factor
accounting for the instability of a+D
mutant
Ilv5p in derepressed petite cells, we nevertheless explored the notion
that Hsp78 functions together with some protease activity directed to
a+D
mutant Ilv5p, particularly in light of
the findings that the regulatory Clp subunits in E. coli
(20), as well as the ortholog of Hsp78, ClpB, are not essential for
protease activity.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 7.
Hsp78 activates the degradation of
a+D mutant Ilv5p by the
Pim1p protease. A, o derivatives of
wild-type strain 14CWW (WT), a+D mutant
W327R, or isogenic strains carrying a null-mutation in the
HSP78 gene (hsp78 ), were grown to mid-log
phase in raffinose medium and the relative amount of Ilv5p in cell
extracts from each strain was then analyzed by Western blotting using
porin as a loading control. B, a plasmid containing
HSP78 whose expression is under the constitutive TEF
promoter (pTEF-HSP78) or a control, empty plasmid (pRS416),
were transformed into o derivatives of wild-type strain
14CWW (WT), or a+D mutant W327R and grown to
mid-log phase in glucose medium. The levels of Ilv5p were determined as
in A. C, o derivatives of
wild-type strain 14CWW (WT), a+D mutant
W327R, or isogenic strains carrying a null-mutation of the
PIM1 gene (pim1 ) were grown to mid-log phase
in raffinose medium and analyzed as in A.
|
|
We next determined whether constitutive expression of Hsp78 in glucose
medium destabilizes a+D
mutant Ilv5p.
To this end, we constructed the centromeric plasmid p416TEFHSP78, which contains HSP78 under the
control of the translation elongation factor promoter, which is
not glucose-repressed. This plasmid, or a control plasmid with no
insert (pRS416), was transformed into wild-type (14CWW
o)
and a+D
mutant (W327R
o)
o strains. These strains were then grown in glucose
medium, where the mutant protein is normally stable, and the level of
Ilv5p was determined by Western blotting. As expected,
a+D
mutant Ilv5p was stable in the strain
containing the control plasmid (Fig. 7B). In striking
contrast, the level of the mutant protein was now significantly lower
when HSP78 expression was under the control of the
constitutive TEF promoter. These data suggest that Hsp78 may function
in concert with one or more proteins to effect the turnover of
a+D
mutant Ilv5p.
A major protease of S. cerevisiae mitochondrial matrix
proteins is the Pim1p protease, which is an ortholog of the Lon
protease in E. coli (22). Besides its protease function,
Pim1p is also required for the maintenance of
+ mtDNA
(23). To determine whether Pim1p is involved in the degradation of
a+D
mutant Ilv5p, we deleted the
PIM1 gene in wild-type and a+D
mutant W327R
° strains and compared the abundance of the wild-type and mutant Ilv5p by Western blotting of extracts from cells grown in
raffinose medium. This experiment (Fig. 7C) shows that
deletion of PIM1 completely reverses the instability of the
a+D
mutant Ilv5p in
° cells grown in
raffinose medium, indicating that Pim1p is responsible for the
proteolytic degradation of a+D
mutant Ilv5p.
Because PIM1 expression is not glucose-repressible (data not
shown), these data further suggest that Hsp78 cooperates with Pim1p for
protease activity.
 |
DISCUSSION |
In this study, we show that a+D
Ilv5p
mutant proteins, which give rise to a
+ mtDNA
instability phenotype, have a dramatically altered localization within
mitochondria compared with wild-type and a
D+
proteins. We also show that the a+D
Ilv5p
mutants are selectively degraded in 
and
o petite cells grown on a non-repressing, fermentable
carbon source. This selective degradation is determined by the ClpB
ortholog, Hsp78, a glucose-repressible mitochondrial chaperone, and the Pim1p protease, an ortholog of the E. coli Lon protease. Our
results suggest that Pim1p works in concert with Hsp78 and implicate a role for wild-type mtDNA in modulating Pim1p protease activity.
A Relation between a+D
Mutant Ilv5p
Organization and mtDNA Stability--
The
a+D
Ilv5p-GFP's are distributed in
mitochondria as a few (5-10) punctate structures, in striking contrast
to the largely reticular distribution of wild-type and
a
D+ Ilv5p-GFPs. A number of observations
support the conclusion that the
+ mtDNA instability
phenotype associated with the a+D
Ilv5p
mutants is a direct consequence of the unusual organization of these
proteins within mitochondria. First, the punctate structures are not
observed for wild-type or a
D+ mutant forms of
Ilv5p in which
+ mtDNA is stable. Second, the weak
a+D
mutant Ilv5p-GFP has a more reticular
distribution underlying its punctate foci than does the strong
a+D
mutant. Finally, co-expression of
wild-type and a+D
mutant proteins, which
results in a suppression of the
+ mtDNA instability
phenotype and temperature sensitivity of a+D
cells grown on a non-fermentable carbon source (10), also results in a
redistribution of the mutant protein from a punctate to a largely
reticular structure. These observations correlate well with the
difference in biochemical fractionation between the
a+D
class of Ilv5p mutant proteins and that
of wild-type and the a
D+ Ilv5p mutant: both
of the a+D
mutant proteins have a marked
decrease in detergent solubility compared with wild-type and
a
D+ mutant Ilv5p. The extent of the
insolubility of Ilv5p in the strong and weak mutants correlates with
the observed differences in their punctate distribution in mitochondria
and their mtDNA instability phenotypes. These effects can be explained
in part by the propensity of the a+D
mutant
proteins to self-associate, probably into aggregates, which may be
disrupted by interaction with wild-type Ilv5p. Finally, in cells
expressing the a+D
mutant proteins,
mitochondrial morphology appears normal, making it unlikely that the
mtDNA instability phenotype associated with these mutant proteins is
caused by the known mtDNA instability observed in cells with gross
defects in mitochondrial morphology (24).
What is the mechanism by which the aberrant organization of
a+D
mutant proteins leads to the instability
of
+ mtDNA? It is unlikely that the presence of
a+D
mutant Ilv5p in mitochondria leads to a
complete block in the segregation of nucleoids because
a+D
mutants grown in a fermentable carbon
source produce stable 
petites (10). We showed
previously that the affected residues in a+D
ilv5 mutants lie on the surface of the protein and proposed
that this might affect intermolecular interactions of the mutant
proteins (10). In preliminary experiments, we have identified several proteins present in mtDNA nucleoids that are also associated with wild-type and a+D
mutant forms of Ilv5p.
Moreover, the relative abundance of some of these nucleoid proteins in
the Ilv5p complexes differs depending on whether the complex was
isolated from wild-type or a+D
mutant
strains. Experiments are currently in progress to characterize further
the composition and properties of those complexes. These altered
interactions of the a+D
mutant forms of Ilv5p
with other nucleoid proteins combined with its tendency to aggregate
could reflect differences in mtDNA packing that might, for example,
affect intramolecular mtDNA recombination events leading to the
formation of 
mtDNAs. In this connection, we know from
previous studies that when overexpressed, Ilv5p effectively suppresses
the loss of
+ mtDNA in cells lacking the mtDNA packaging
protein, Abf2p (4), thus implicating a role for Ilv5p in the
organization of mtDNA.
Factors Affecting the Stability of a+D
Mutant Ilv5p--
We found unexpectedly that
a+D
mutant Ilv5p forms are unstable in petite
cells grown under derepressing conditions. The instability of
a+D
mutant Ilv5p is not just a consequence of
respiratory deficiency because the mutant protein was stable in
+ cells grown in the presence of antimycin A or
oligomycin. Interestingly, unlike the mtDNA-instability phenotype, the
instability of a+D
mutant Ilv5p appeared to
be unrelated to the punctate organization of the protein, because it
was equally unstable when dispersed in mitochondria by co-expression
with wild-type Ilv5p.
The degradation of a+D
mutant Ilv5p in petite
cells is activated by Hsp78, a member of the Clp/Hsp100 family of heat
shock proteins (21). We suspected that Hsp78 might be involved in the
degradation of a+D
mutant Ilv5p because of
its high degree of similarity to ClpA, a regulatory ATP-dependant
subunit of the E. coli Clp protease, and because the
expression of Hsp78 is glucose-repressible (18, 21). Before this study,
the only known in vivo mitochondrial functions for Hsp78
were its requirement for mitochondrial thermotolerance under extreme
heat stress (25) and the observation that it could substitute for a
defective mt-Hsp70 in an ssc1-3 mutant (26). Although the a+D
Ilv5p mutant protein is only
marginally stabilized in petite cells with an hsp78
mutation, constitutive expression of HSP78 in
glucose-repressed petite cells results in the clear destabilization of
the mutant Ilv5p. These data provide direct evidence for a role of
Hps78 in the degradation of a+D
Ilv5p and
suggest that under derepressing conditions, one or more other
chaperones can substitute for Hsp78. Cooperation of Hsp78 with other
heat-induced chaperones was previously suggested in its role in
reactivation of the mitochondrial protein synthesis apparatus after
heat stress (25). Hsp78 has also been shown to be capable of
substituting for Hsp104 in mediating cellular thermotolerance when
misexpressed in the cytosol (25), suggesting that, like Hsp104, Hsp78
may act to disassemble insoluble protein complexes (27). However, Hsp78
is not acting in this way for a+D
mutant
Ilv5p, because Hsp78 is still necessary for degradation of the mutant
protein when it is largely disaggregated when co-expressed with
wild-type Ilv5p. A likely scenario is that the chaperone activity of
Hsp78 alters the conformation of a+D
mutant
Ilv5p, so that it becomes a target for Pim1p protease activity.
Deletion of PIM1 completely eliminated the instability of
a+D
mutant Ilv5p in petite cells grown in
raffinose medium. This finding establishes that Pim1p can degrade an
abnormal isoform of an endogenous protein in vivo. Pim1p has
been shown to be involved in the turnover of some unassembled subunits
of mitochondrial complexes such as the F1 ATPase and mitochondrial
ribosomal proteins (23, 28), and in vitro studies have shown
that Pim1p degrades chimeric and foreign misfolded proteins (29, 30).
With a+D
mutant Ilv5p, Pim1p is likely to be
recognizing a subtle alteration in the mutant protein rather than an
aggregated population, because it is still degraded when largely
disaggregated by the wild-type protein. Indeed, it is unlikely that the
a+D
mutant Ilv5p is grossly misfolded,
because it retains its enzymatic activity in branched chain amino acid
biosynthesis (10) and interacts with wild-type Ilv5p when co-expressed.
Aside from the turnover of unassembled or aberrant proteins, the
proteolytic activity of Pim1p is required for the stability of
+ mtDNA (pim1
cells produce

petites (22, 23, 31) and for the expression of the
mitochondrial COX1 and COB genes (32, 33). In
most yeast strains, these genes contain introns, some of which encode
maturases that function in the splicing of the intron that encodes
them. The requirement for Pim1p in the expression of these genes occurs
at multiple levels, including maturase-dependent splicing,
RNA stability, and translation (32). Although it is not clear how Pim1p
functions in these diverse activities, or in maintaining the integrity
of
+ mtDNA, these findings suggest that there is a
significant degree of control over the substrate specificity and
activity of the Pim1p protease. Our findings add new dimensions to this
control that include the participation of Hsp78 and
+
mtDNA in regulating Pim1p activity. Additional studies will be required
to determine whether these effects occur by direct modulation of Pim1p
protease activity or by substrate presentation. Finally, it is
intriguing that, like the Lon protease in E. coli
(34, 35), the human ortholog of PIM1 has been demonstrated
to bind DNA, specifically to single-stranded sequences in mtDNA (36). These observations have led to speculation that Lon proteases might use
DNA binding to control mtDNA metabolism by degrading regulatory
proteins at sites adjacent to promoters (33). It is reasonable to
imagine therefore that an interaction between mtDNA and Pim1p could
modulate its activity and substrate specificity.
 |
ACKNOWLEDGEMENTS |
We thank members of our laboratory for
critical comments on the manuscript.
 |
FOOTNOTES |
*
This work was supported by Grant GM33510 from the National
Institutes of Health and Grants I-0642 and I-1211 from The Robert A. Welch Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 214-648-1465;
Fax: 214-648-1488; E-mail: ronald.butow@UTSouthwestern.edu.
Published, JBC Papers in Press, October 14, 2002, DOI 10.1074/jbc.M209071200
 |
ABBREVIATIONS |
The abbreviations used are:
mtDNA, mitochondrial
DNA;
GFP, green fluorescent protein;
TTC, 2,3,5-triphenyltetrazolium
chloride.
 |
REFERENCES |
| 1.
|
Contamine, V.,
and Picard, M.
(2000)
Microbiol. Mol. Biol. Rev.
64,
281-315[Abstract/Free Full Text]
|
| 2.
|
Kakar, S. N.,
and Wagner, R. P.
(1964)
Genetics
49,
213-222[Free Full Text]
|
| 3.
|
Petersen, J. G. L.,
and Holmberg, S.
(1986)
Nucleic Acids Res.
14,
9631-9651[Abstract/Free Full Text]
|
| 4.
|
Zelenaya-Troitskaya, O.,
Perlman, P. S.,
and Butow, R. A.
(1995)
EMBO J.
14,
3268-3276[Medline]
[Order article via Infotrieve]
|
| 5.
|
Diffley, J. F.,
and Stillman, B.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7864-7868[Abstract/Free Full Text]
|
| 6.
|
Megraw, T. L.,
and Chae, C. B.
(1993)
J. Biol. Chem.
268,
12758-12763[Abstract/Free Full Text]
|
| 7.
|
Newman, S. M.,
Zelenaya-Troitskaya, O.,
Perlman, P. S.,
and Butow, R. A.
(1996)
Nucleic Acids Res.
24,
386-393[Abstract/Free Full Text]
|
| 8.
|
Zelenaya-Troitskaya, O.,
Newman, S. M.,
Okamoto, K.,
Perlman, P. S.,
and Butow, R. A.
(1998)
Genetics
148,
1763-1776[Abstract/Free Full Text]
|
| 9.
|
MacAlpine, D. M.,
Perlman, P. S.,
and Butow, R. A.
(2000)
EMBO J.
19,
767-775[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Bateman, J. M.,
Perlman, P. S.,
and Butow, R. A.
(2002)
Genetics
161,
1043-1052[Abstract/Free Full Text]
|
| 11.
|
Biou, V.,
Dumas, R.,
Cohen-Addad, C.,
Douce, R.,
Job, D.,
and Pebay-Peyroula, E.
(1997)
EMBO J.
16,
3405-3415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Herskowitz, I.,
and Jensen, R. E.
(1991)
Methods Enzymol.
194,
132-146 |